Search research articles
Contact Us
Filters
Showing results (341-350 of 361) with videos related to
Page
of 37
Sort By:
The Journal of Infection
|
April 25, 2024
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Julien De Greef, Dina Averbuch, Laura Tondeur, et al.
Nature
|
January 7, 2026
Albumin orchestrates a natural host defence mechanism against mucormycosis
Antonis Pikoulas, Ioannis Morianos, Vassilis Nidris, et al.
Microbial Cell (Graz, Austria)
|
July 12, 2018
Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms
Patrick Van Dijck, Jelmer Sjollema, Bruno P Cammue, et al.
Leukemia
|
July 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Anne Mea Spanjaart, Per Ljungman, Gloria Tridello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2023
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study
Sammy Huygens, Albert Dunbar, Jochem B Buil, et al.
Eclinicalmedicine
|
December 28, 2023
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party
Olaf Penack, Gloria Tridello, Urpu Salmenniemi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
Monique Terwijn, Wim L J van Putten, Angèle Kelder, et al.
Cancers
|
February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
Jeroen Janssen, Bob Löwenberg, Markus Manz, et al.
Intensive Care Medicine
|
March 21, 2024
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Matteo Bassetti, Daniele R Giacobbe, Christina Agvald-Ohman, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 361) with videos related to
Sort By:
Page
of 37
The Journal of Infection
|
April 25, 2024
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Julien De Greef, Dina Averbuch, Laura Tondeur, et al.
Nature
|
January 7, 2026
Albumin orchestrates a natural host defence mechanism against mucormycosis
Antonis Pikoulas, Ioannis Morianos, Vassilis Nidris, et al.
Microbial Cell (Graz, Austria)
|
July 12, 2018
Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms
Patrick Van Dijck, Jelmer Sjollema, Bruno P Cammue, et al.
Leukemia
|
July 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Anne Mea Spanjaart, Per Ljungman, Gloria Tridello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2023
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study
Sammy Huygens, Albert Dunbar, Jochem B Buil, et al.
Eclinicalmedicine
|
December 28, 2023
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party
Olaf Penack, Gloria Tridello, Urpu Salmenniemi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
Monique Terwijn, Wim L J van Putten, Angèle Kelder, et al.
Cancers
|
February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
Jeroen Janssen, Bob Löwenberg, Markus Manz, et al.
Intensive Care Medicine
|
March 21, 2024
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Matteo Bassetti, Daniele R Giacobbe, Christina Agvald-Ohman, et al.
Blood Advances
|
April 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi, et al.
Page
of 37